PDA

View Full Version : Dissolution Discussion


Pages : 1 2 3 4 5 6 7 [8] 9

  1. F2 Test Spreadsheet
  2. To filter or not to filter...?
  3. higher %SDS may be more discriminating?
  4. Sodium Docecyl Sulfate (SLS) Manufacturer
  5. dissolution problem of flunarizine capsule
  6. Biowaivers
  7. How discriminating a method should be?
  8. dissolution of aripiprazole
  9. What about SR tablets?
  10. Q value
  11. F1&F2 Excel Sheet
  12. Ivivc Fed Condition For Enteric Polymers
  13. Russian guidelines
  14. Tier 2 (Enzymatic) Disso Method for Cross-linked Soft Gel Capsules-Japan
  15. Gelatin Mass Remaining in Vessel
  16. dissolution and assay testing method for Alendronate Sodium and Cholecalciferol combi
  17. Development of dissolution test
  18. S3 result with no assignable cause
  19. Calibration Failures
  20. Dissolution Profile Comparison for Delayed Release Tablets
  21. Drug Release morethan 120%
  22. 2 Stage disssolution 0.1 M HCL/ pH 5.5
  23. Dissolution vs Disintegration
  24. Calculation of ovedosage formulations
  25. LC Dissolution Linearity Experiment
  26. Dissolution of Phenylephrine HCl pellets
  27. Dissolution of Terazocin Tablet
  28. what happened at high temp/humidity?
  29. Artemether Lumefantrine (Coartem) dissolution test
  30. Pepsin in Dissolution Medium
  31. dissolution discriminatory medium
  32. DDG Bulletin Board Upgraded to v3.7.0: New Features!
  33. Troubleshooting Dissolution with Pancreatin...How much???
  34. babasaheb aware
  35. Dissolution method development for ER tab
  36. Line extension of tablets
  37. Dissolution within the CTD structure
  38. Definition of "DISSOLUTION" Profile
  39. General Disintegration of Orally disintegrating tablets
  40. Regulatory Discussion Regulatory aspects on vitamins
  41. Peak vessels
  42. Regulatory Discussion comments on
  43. Robustness of Dissolution
  44. differences in drug product filing for US and EU
  45. Calibration Help
  46. biowavers and rpm
  47. Add enzyme first then surfactant
  48. multisource-tablets and comparator-capsules
  49. Calibration vibration - how many vessels to test
  50. Dissolution Theory SDS or SLS in pH6.8 USP buffer
  51. extent of gelatin crosslinking
  52. Troubleshooting Disso issues with Phenobarbital USP test
  53. Calibration Is auto calibration mandatory for Dissolution?
  54. Losartan stability dissolution
  55. Method Development Disso testing of sub-microgram dose strength capsules
  56. Dissolution Theory Sink Condition in Type III and VII
  57. Ezetimibe
  58. Method Development Atorvastatin Tablets
  59. Rant dissocal-RS tablets
  60. Discriminatory medium
  61. Dissolution Theory pH profile for a new MR formulation
  62. General Interpretation of Q in ER dosage forms in USP monographs
  63. 2 litre dissolution testers
  64. esomeprazole dissolution
  65. Normalize with Infinity Spin?
  66. Dissolution of DHAPPQ or Dihydroartemisinin and Piperaquine Phosphate tablet.
  67. Preparation of a SLS-solution
  68. Troubleshooting Azathioprine Tablet Dissolution.
  69. Method Development Dissolution Analysis in Microplate Readers
  70. Surface Area vs Particle Size
  71. Qc Media
  72. Troubleshooting Pancreatin fouls HPLC column
  73. SLS is known to inactivate enzymes
  74. Sink Conditions
  75. Profile Dissolution For Prodrugs
  76. DDG Annual Meeting?
  77. Method Development Lastest method to degas?
  78. Method Development Dissolution test for GLIMEPIRIDE tablets
  79. General Sampling Technique
  80. Bis-tris buffer
  81. Diazepam dissolution solution stability
  82. Peak Vessel
  83. Validation filter test
  84. General Intrisic dissolution - face up or down?
  85. General Paddle height for peak vessel
  86. General Non-aqueous injection
  87. Calibration Media Volume
  88. CO2 in medium?
  89. Q Value
  90. Method Development Sildenafil Citrate
  91. Regulatory Discussion Dissolution Testing Condition for Profile Comparison
  92. Advice on IVIVC
  93. Capsules are giving me troubles
  94. Need help with USP 4 dissolution method
  95. Method Development oil (lipid) based formulation
  96. What's the rationale
  97. General Alprazolam Tablets - Disso. Media prep
  98. Dose dumping test?
  99. General Difference In Dissolution By Using Different Makes
  100. General Calibrating tablet
  101. Need help Percent CV and calculation of similarity factor (f2)
  102. Reporting Disso Results
  103. Dissolution Theory DIssolution of montelukast sodium granules (innovater) singulair 4mg
  104. Media with 4% BSA
  105. Regulatory Discussion disintegration
  106. specific molar absorptivity of ibuprofen
  107. Troubleshooting Effect of Dearition/Degass on Dissolution
  108. disintegration of sartans
  109. Dissolution Theory Case 1 - Case 2 - Case 3
  110. Method Development Tacrolimus Ointment- Dissolution
  111. Degassing - He Sparge vs Commercial System
  112. Tacrolimus ointment Dissolution
  113. Calibration Calibration tablets
  114. Troubleshooting Pancreatin in Autosampler Lines
  115. Dissolution Theory asympote mean
  116. General Use/Removal of Filter Changer
  117. Apparatus 3 suitability
  118. Dissolution of mefenamic acid tablets
  119. montelukast
  120. Troubleshooting Effect of curing on dissolution profiles?
  121. General peak dissolution vessel
  122. Sustained release dissolution
  123. Need of discriminating media for DR tablets
  124. General Dissolution profile
  125. Stability of SDS concentrate solutions
  126. Regulatory Discussion f2
  127. Bulletin Board Defacement (Restored From 10/22 Backup)
  128. Troubleshooting Occasional slow release from enteric coated tablets
  129. Dissolution Medium for Butoconazole Nitrate
  130. Abbreviation of UPVC
  131. Necessity of media replacement calculation
  132. Dissolution medium for Vaginal tablets of poorly soluble durg
  133. Validation Verification of USP dissolution method
  134. Calibration Qualification of 100 mL Vessels
  135. PVT- New Acceptance Ranges
  136. Apparatus 3 Calibration Problems
  137. Validation - robustness
  138. General Hello All
  139. Validation Placebo in dissolution
  140. Fassif and Fessif
  141. Method Development Buffer vs NaOH
  142. Phenytoin sodium BCS
  143. Troubleshooting Tris-HCl Buffer pH 8.0 dissolution meida
  144. Slightly off-topic F2 calculation use
  145. tacrolimus dissolution
  146. Capsule shells increase dissolution speed
  147. Troubleshooting 0.01M HCl and Pepsin
  148. Epalrestat
  149. Dissolution of Vaginal Tablets or Capsules
  150. Error Bar on Dissolution Profile
  151. sink conditions, acceptance range
  152. Method Validation - Precision on pooled sample
  153. Troubleshooting Floating of Tablet in Basket
  154. Validation Analytical and Test methods
  155. Regulatory Discussion dissolutionmatching in multimedia
  156. General Testing Stage 2/3 for Multiple components
  157. General Must all 6 units of a disso test be tested at once?
  158. Method Development Bisacodyl enteric coated tablets
  159. Method Development Biorelevant media
  160. Regulatory Discussion STD curves
  161. Method Development Assigining a Q Value
  162. Basket mesh sinkers
  163. General Dissolution Bowel
  164. Dissolution acceptance criteria
  165. Method Development Lubiprostone
  166. 2 buffers 1 pH
  167. hi all
  168. SSiF
  169. Microbial growth affect on dissolution
  170. Biowaiver
  171. General Correct for volume change
  172. Calibration of testers every 6 months
  173. General IR tablets dissolution test
  174. Dissolution Theory Discriminating media for Montelukast
  175. High Dissolution Results
  176. Gelatin Sample Filtering
  177. Cost Savings in Dissolution
  178. Dissolution Tester Calibration
  179. Regulatory Discussion Rabeprazole Na
  180. Method Development Lower dissolution results
  181. Method Development Subcutaneous injectable suspension/IVIC
  182. General Sds
  183. General Diss
  184. Method Development capsule shell interference
  185. Chromatography for Tacrolimus Dissolution
  186. Dextromethorphan Dissolution
  187. Overencapsulated MR tabs
  188. Dissolution vs particle size
  189. Database Problems / Missing Posts & Accounts
  190. bio-equivalence
  191. General Librarian
  192. extended release criteria L1-L2-L3
  193. General Dissolution for best Bioequivalence
  194. Working With UV
  195. Calibration OTC In-house calibrator tablets
  196. Calibrator Dissolution Rate and Paddle Speed
  197. Method Development Amisulprid
  198. Tamsulosin
  199. Method Development HPMC Controlled Release Tablet Variability
  200. Method Development Dissolution Development method
  201. Troubleshooting Polycarbonate Vessels.
  202. Uhplc
  203. Bootstrap data
  204. Benserazide + Levodopa Capsules Formulation
  205. Dissolution Theory Dissolution of Profile of poorly soluble Drugs
  206. Detection of non-UV absorbing molecule
  207. selection of dissolution medium for floating tablets.
  208. Degradation of drug in dissolution media
  209. Aspirin Class
  210. stomach residence time
  211. Roxithromycin tablets Dissolution
  212. General Nifedipi
  213. General Nifedipine extended release tablet.
  214. Bromazepam tablets
  215. Dissolution Theory 4.5 buffer
  216. Acetaminophen ibuprofen dissolution
  217. Suspension Dissolution
  218. Calibration Calibratin Frequency
  219. MR the 8 hours
  220. Validation Sibutramine Standard!
  221. Tier I and Tier II
  222. Half-Change Method
  223. Dissolution of ziprasidone
  224. Troubleshooting OE Quetiapine Tablets
  225. Troubleshooting Dealing with evaporation of medium
  226. % Dissolved
  227. dissolution calibrator
  228. Thermometer Certification Dilemma
  229. Calibration Dissolution Apparatus
  230. UV first derivative analysis
  231. Alpha Lipoic Acid help
  232. Surfactant in 1.2 pH media
  233. Dissolution Theory pH importance in Paracetamol dissolution
  234. Method Development Eletriptan HBr
  235. DDG Community Bulletin (04-01-09)
  236. Levonorgestrel + Ethinylestradiol dissolution
  237. Method Development Novel dissolution techniques
  238. Dissolution Theory Dissolution (6 bowels funda???)
  239. Calibration New USP Dissolution Performance Verification Tests
  240. General Review
  241. Solubility determination and validation!
  242. calibration curve
  243. Method Development How one should validate non-regulated methods?
  244. Dissolution and assay method!
  245. Buffer response in HPLC!
  246. Stability indicating Dissolution method
  247. Lomefloxacin Hcl Tablet Dissolution
  248. Calibration Franz Cell
  249. Regulatory Discussion USP Dissolution Tester-New PVT approach
  250. Interpretation of Dissolution Q limits